FDA.reportPublic FDA data

24 HR ASA 162.5 MG Extended Release Oral Capsule [Durlaza]

RxCUI
1665362
RxNorm name
24 HR ASA 162.5 MG Extended Release Oral Capsule [Durlaza]
Display name
24 HR ASA 162.5 MG Extended Release Oral Capsule [Durlaza]
Full name
24 HR ASA 162.5 MG Extended Release Oral Capsule [Durlaza]
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4c2a1403-3862-1efd-0a91-444989222b37Durlaza 162.5 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR aspirin 162.5 MG Extended Release Oral Capsule [Durlaza] [SBD] · 24 HR ASA 162.5 MG Extended Release Oral Capsule [Durlaza] [SY] · Durlaza 162.5 MG 24HR Extended Release Oral Capsule [SY]46These highlights do not include all the information needed to use DURLAZA ™ safely and effectively. See full prescribing information for DURLAZA. DURLAZA (aspirin) Extended Release Capsules, for oral use Initial U.S. Approval:201520150925